Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Top Five (Non-COVID) Pharma Stories Of 2020

Jan 20 2021

• By Kevin Grogan

The Top Five (Non-COVID) Pharma Stories Of 2020 — • Source: Shutterstock

Related Content

UK Vaunts 'New Era' In Drug Approvals

Jan 04 2021

Biogen’s Twisting Path To The Aducanumab Advisory Committee

Nov 05 2020

Novartis CEO: Inclisiran Could Be Largest Medicine In NHS History

Jan 30 2020

AZ's Alexion Acquisition Looks Astute Bit Of Business

Dec 13 2020

Novartis' Inclisiran Grounded In The US By FDA Inspection Restrictions

Dec 21 2020

EU First To Approve Novartis’s Cholesterol Drug Leqvio

Dec 11 2020

Pharma Breathes Sigh Of Relief Over Brexit Deal

Dec 24 2020

UK Authorizes ‘Gamechanger’ AstraZeneca Vaccine Despite Data Doubts

Dec 30 2020

Aducanumab Panel Pushes Back On Rosy FDA Outlook, Could Derail A Swift Approval

Nov 07 2020

Outlook For Biogen's Aducanumab Brightens Based On FDA Clues

Nov 04 2020

Year Of NASH Upheaval Means Incremental Data At AASLD

Nov 18 2020

Intercept’s CRL Just Continues Upheaval In NASH

Jun 29 2020

AstraZeneca Gilead Merger Intriguing But Unlikely

Jun 08 2020

Gilead Buys Pipeline-In-A-Product With $21bn Immunomedics Deal

Sep 14 2020

RESOLVE-IT Failure Dashes Genfit's NASH Hopes

May 12 2020

Related Companies

Bristol Myers Squibb Company

Celgene Corporation

AbbVie Inc.

Allergan plc

Gilead Sciences, Inc.

Immunomedics, Inc.

Forty Seven Inc.

AstraZeneca PLC

Alexion Pharmaceuticals Inc.

Novartis AG

The Medicines Company

Biogen, Inc.

Eisai Co., Ltd.

Intercept Pharmaceuticals, Inc.

Genfit SA

Galmed Pharmaceuticals Ltd.

Inventiva S.A.

89bio, Inc.

Pfizer Inc.

BioNTech SE

Additional Topics

M & A Companies Strategy Commercial Deals Neurology Liver & Hepatic BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window